These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effects of peak and mid-luteal estradiol levels on in vitro fertilization outcome. Moraloğlu Ö; Tonguc EA; Özel M; Özakşit G; Var T; Sarikaya E Arch Gynecol Obstet; 2012 Mar; 285(3):857-62. PubMed ID: 21938500 [TBL] [Abstract][Full Text] [Related]
5. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial. Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847 [TBL] [Abstract][Full Text] [Related]
6. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer. Drakakis P; Loutradis D; Vomvolaki E; Stefanidis K; Kiapekou E; Anagnostou E; Anastasiadou K; Milingos S; Antsaklis A Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276 [TBL] [Abstract][Full Text] [Related]
7. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Lukaszuk K; Liss J; Lukaszuk M; Maj B Fertil Steril; 2005 May; 83(5):1372-6. PubMed ID: 15866571 [TBL] [Abstract][Full Text] [Related]
8. Impact of peak/mid luteal estradiol on pregnancy outcome after intracytoplasmic sperm injection. Rehman R; Hussain Z; Zahir H; Khan R J Pak Med Assoc; 2014 Jul; 64(7):780-4. PubMed ID: 25255586 [TBL] [Abstract][Full Text] [Related]
9. Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization. Florêncio RS; Meira MSB; Cunha MVD; Camarço MNCR; Castro EC; Finotti MCCF; Oliveira VA JBRA Assist Reprod; 2018 Mar; 22(1):8-14. PubMed ID: 29338136 [TBL] [Abstract][Full Text] [Related]
10. Luteal estrogen supplementation in pregnancies associated with low serum estradiol concentrations. Kaider AS; Coulam CB Early Pregnancy (Cherry Hill); 2000 Jul; 4(3):191-9. PubMed ID: 11727011 [TBL] [Abstract][Full Text] [Related]
11. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study. Ata B; Yakin K; Balaban B; Urman B Hum Reprod; 2008 Mar; 23(3):668-73. PubMed ID: 18192671 [TBL] [Abstract][Full Text] [Related]
12. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Sahu B; Ozturk O; Ranierri M; Serhal P Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140 [TBL] [Abstract][Full Text] [Related]
13. The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial. Ghanem ME; Sadek EE; Elboghdady LA; Helal AS; Gamal A; Eldiasty A; Bakre NI; Houssen M Fertil Steril; 2009 Aug; 92(2):486-93. PubMed ID: 19464001 [TBL] [Abstract][Full Text] [Related]
14. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle. Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238 [TBL] [Abstract][Full Text] [Related]
15. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376 [TBL] [Abstract][Full Text] [Related]
16. Serum estradiol and progesterone in the mid-luteal phase predict clinical pregnancy outcome in IVF/ICSI cycles. Sonntag B; Loebbecke KC; Nofer JR; Kiesel L; Greb RR Gynecol Endocrinol; 2013 Jul; 29(7):700-3. PubMed ID: 23772781 [TBL] [Abstract][Full Text] [Related]
17. Stimulation day-six serum estradiol: a predictive indicator for the probability of embryo cryopreservation in IVF/ICSI cycles. El Maghraby HA; Mahdi M; El Arab MS; Mabrouk M; Ghi T; Farina A J Obstet Gynaecol Res; 2009 Apr; 35(2):326-9. PubMed ID: 19335799 [TBL] [Abstract][Full Text] [Related]
18. Extension of GnRH agonist through the luteal phase to improve the outcome of intracytoplasmic sperm injection. Isikoglu M; Ozgur K; Oehninger S J Reprod Med; 2007 Jul; 52(7):639-44. PubMed ID: 17847764 [TBL] [Abstract][Full Text] [Related]
19. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Pirard C; Donnez J; Loumaye E Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673 [TBL] [Abstract][Full Text] [Related]
20. The decline in serum estradiol on the second day after oocyte retrieval affects the outcome of IVF/ICSI-ET treatment in high ovarian responders. Bai X; Zhang Y; Liu S; Qu D; Su H; Ren H; Li Y Gynecol Endocrinol; 2017 Jun; 33(6):452-457. PubMed ID: 28277137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]